Medical Care Technologies Inc. (OTCID:MDCE) Outlines Path to Scale AI-Powered Software Revenue After $250,000 First Agreement
The first software payment has been initiated, while subsidiaries have completed an initial six-figure memorabilia sale to Topps.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Medical Care Technologies (MDCE) outlined commercialization plans following its first external enterprise software agreement, valued at up to $250,000.
The agreement was announced October 14, execution is underway, and the first payment has been initiated. The company is evaluating additional software opportunities. StrainScan Pro enterprise demonstrations continue as it works toward first enterprise clients. Subsidiaries Infinite Auctions and Real Game Used completed an initial six-figure game-worn memorabilia sale to Topps; additional supply discussions remain open. Melanoma Scan Beta and Wound Monitoring remain in development without regulatory clearance. The company expects another round of internal Melanoma Scan Beta evaluation results in the near term.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major pointSoftware agreement worth up to $250,000 is in execution; the first payment has been initiated. 77% of market cap
- Moderate pointSubsidiaries completed an initial six-figure memorabilia sale to Topps, with Real Game Used providing photo-match authentication.
- Minor point. Forward-looking: it has not happened yet and may not happen.Additional software opportunities are under evaluation using the same deployment model.
- Minor point. Forward-looking: it has not happened yet and may not happen.Melanoma Scan Beta internal evaluation results are expected in the near term on the corporate website.
Negative
- Moderate pointAdditional memorabilia supply discussions, including historic New York Knicks material, have not closed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MESA, AZ / ACCESS Newswire / October 15, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today described the operating framework it is using to build on the first paid software agreement announced October 14.
That agreement is valued at up to
Four tracks are currently open:
Software commercialization
The October 14 agreement establishes the first external software revenue line. Execution under that agreement is underway. The Company is also evaluating additional software opportunities that fit the same deployment model. No additional agreements are being announced in this release.
StrainScan Pro
Enterprise demonstrations continue across agriculture, food distribution, and restaurant service. The platform is being shown as a configurable visual inspection layer for operators in markets the Company has previously described as multi-trillion and multi-hundred-billion dollar in scale. Feedback from those sessions is being used to refine workflows as the Company works toward first enterprise clients.
Infinite Auctions and Real Game Used
The subsidiaries completed an initial six-figure game-worn memorabilia sale to Topps, with Real Game Used providing photo-match authentication. Discussions continue on additional supply, including historic New York Knicks material following the franchise's 2026 championship. Those discussions are ongoing and have not closed.
Melanoma Scan Beta and Wound Monitoring
Both applications remain in active development. Melanoma Scan Beta continues to accept human-submitted images, with a new round of internal evaluation results expected on the corporate website in the near term. Wound Monitoring remains in internal technical evaluation following the results posted October 12. Neither application has regulatory clearance.
"The first software payment shows the build can produce revenue," said Marshall Perkins, CEO of Medical Care Technologies. "We now have a paid software agreement in motion, enterprise demonstrations running, subsidiary transactions with a major collectibles partner, and health imaging platforms advancing through testing. The objective is to grow revenue across those tracks. That is an objective, not a projection, and it is the direction the Company is executing toward."
The Company is not providing revenue guidance or share-price commentary. Progress on each track will be reported as it occurs.
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. Visit: https://www.medicalcaretechnologies.com
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding commercialization priorities, ongoing demonstrations, negotiations, and development timelines. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.
Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: marshall@medicalcaretechnologies.com
Website: https://www.medicalcaretechnologies.com
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much is Medical Care Technologies' first external software agreement worth?
The agreement is valued at up to $250,000, and the first payment has been initiated. Announced October 14, it represents the company's first external enterprise-level software revenue outside its subsidiaries. Execution under the agreement is underway.
What memorabilia sale did Medical Care Technologies' subsidiaries complete with Topps?
Infinite Auctions and Real Game Used completed an initial six-figure game-worn memorabilia sale to Topps. Real Game Used provided photo-match authentication. Discussions about additional supply, including historic New York Knicks material following the franchise's 2026 championship, remain ongoing and have not closed.
What is the status of Medical Care Technologies' Wound Monitoring application?
Wound Monitoring remains in internal technical evaluation following results posted October 12. The application remains in active development and does not have regulatory clearance.